Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Clin Cancer Res. 2018 Mar 19;24(12):2935–2943. doi: 10.1158/1078-0432.CCR-17-3871
NTRK3-Forward: 5′-CACTGCATCGAGTTTGTGGTGCG
ETV6-Reverse: 5′-CTTATGGTTTCCCCACAGTCGAGC
Product: 393 bp
NTRK3:ETV6 sequencing: 5′-CCAACGCTGCACTGGCTG
NFIB-Forward: 5′-GGAACCAAGTCCTACAGGAGACTTTTACC
MTFR2-Reverse: 5′-GCAAGTGTAGGCAAAATGTGTCAAGAAGAG
Product: 372 bp
NFIB:MTFR2 sequencing: 5′-ATCCTTGAGTTTAGAAGGCTTGTGTTGC
MYB-Forward: 5′-CCTTGTAGCAGTACCTGGGAACCTGC
NFIB-Reverse: 5′-TTGGACATTGGCCGGTAAGATGG
Product: 186 bp
MYB:NFIB sequencing: 5′-CCTGTGGAAAGATGGAGGAGCAG